Pesticide resistance in wild mammals - Mechanisms of anticoagulant resistance in wild rodents

Journal of Toxicological Sciences

Volumn 33, Issue 3, 2008, Pages 283-291

  Ishizuka, Mayumi ^a   Tanikawa, Tsutomu ^b   Tanaka, Kazuyuki D ^a   Heewon, Min ^a   Okajima, Fumie ^a   Sakamoto, Kentaro Q ^a   Fujita, Shoichi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Ikari Corporation   (Japan)

Author keywords

Cytochrome P450; Rodent; Rodenticide; Vitamin K epoxide reductase; Warfarin resistance

Indexed keywords

ANTICOAGULANT AGENT; CYTOCHROME P450; MENADIONE EPOXIDE; PESTICIDE; PROADIFEN; RODENTICIDE; WARFARIN;

AMINO ACID SUBSTITUTION; CARBOXYLATION; DETOXIFICATION; DRUG MECHANISM; DRUG METABOLISM; ENZYME ACTIVITY; KINETICS; MOLECULE; MORTALITY; MUTATION; NONHUMAN; PESTICIDE RESISTANCE; PLEIOTROPY; REVIEW; RODENT; WILD ANIMAL;

ANIMALIA; MAMMALIA; RATTUS; RODENTIA;

EID: 48849106431     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.33.283     Document Type: Review

References (56)

1. Ayala, I., Rodríguez, M.J., Martos, N., Zilberschtein, J., Ruíz, I. and Motas, M. (2007): Fatal brodifacoum poisoning in a pony. Can. Vet. J., 48, 627-629.
2. Boyle, C.M. (1960): Case of apparent resistance of Rattus norvegicus Berkenhout to anticoagulant poisons. Nature, 188, 517-525.
3. Cain, D., Hutson, S.M. and Wallin, R. (1998): Warfarin resistance is associated with a protein component of the vitamin K 2,3-epoxide reductase enzyme complex in rat liver. Thromb. Haemostasis, 80, 128-133.
4. Dodsworth, E. (1961): Mice are spreading despite such poisons as warfarin. Minic. Engin. Lond., 3746, 1668.
5. Eason, C.T., Murphy, E.G., Wright, G.R.G. and Spurr, E.B. (2001): Assessment of Risks of Brodifacoum to Non-target Birds and Mammals in New Zealand. Ecotoxicology, 11, 35-48.
6. Fujita, S., Chiba, I., Ishizuka, M., Hoshi, H., Iwata, H., Sakakibara, A., Tanabe, S., Kazusaka, A., Masuda, M., Masuda, Y. and Nakagawa, H. (2001): P450 in wild animals as a biomarker of environmental impact. Biomarkers, 6, 19-25.
7. Furie, B. and Furie, B.C. (1988): The molecular basis of blood coagulation. Cell, 53, 505-518
8. Gebauer, M. (2007): Synthesis and structure-activity relationships of novel warfarin derivatives. Bioorg. Med. Chem., 15, 2414-2420.
9. Goodstadt, L. and Ponting, C.P. (2004): Vitamin K epoxide reductase: homology, active site and catalytic mechanism. Trends Biochem. Sci., 29, 289-292.
10. Guengerich, F.P., Dannan, G.A.., Wright, S.T., Martin, M.V. and Kaminsky, L.S. (1982): Purification and characterization of liver microsomal cytochromes p-450: Electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. Biochemistry, 21, 6019-6030.
11. Guillemette, C. (2003): Pharmacogenomics of human UDP- glucuronosyltransferase enzymes. Pharmacogenomics J., 3, 136-158.
12. Hayes, J.D., Flanagan, J.U. and Jowsey, I.R. (2005): Glutathione transferases. Annu. Rev. Pharmacol. Toxicol., 45, 51-88.
13. Heiberg, A.C., Leirs, H. and Siegismund, H.R. (2006): Reproductive success of bromadiolone-resistant rats in absence of anticoagulant pressure. Pest Manag. Sci., 62, 862-871.
14. Helgeland, L. (1977): The submicrosomal site for the conversion of prothrombin precursor to biologically active prothrombin in rat liver. Biochim. Biophys. Acta., 499, 181-193.
15. Hoshi, H., Masuda, M., Yamamoto, Y., Suimamoto, Y., Kazusaka, A. and Fujita, S. (1995): Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus. Drug Metab. Dispos., 23, 1301-1303.
16. Ishizuka, M., Okajima, F., Tanikawa, T., Min, H., Tanaka, K.D., Sakamoto, K.Q. and Fujita, S. (2007): Elevated warfarin metabolism in warfarin-resistant roof rats (Rattus rattus) in Tokyo. Drug Metab. Dispos., 35, 62-66.
17. Izzo, A.A. (2005): Herb-drug interactions: An overview of the clinical evidence. Fundam. Clin. Pharmacol., 19, 1-16.
18. Jackson, W. and Kaukeinen, D. (1972): Resistance of wild Norway rats in North Carolina to warfarin rodenticide. Science, 176, 1343-1344.
19. Johnston, J.J., Pitt, W.C., Sugihara, R.T., Eisemann, J.D., Primus, T.M., Holmes, M.J., Crocker, J. and Hart, A. (2005): Probabilistic risk assessment for snails, slugs, and endangered honeycreepers in diphacinone rodenticide baited areas on Hawaii, USA. Environ. Toxicol. Chem., 24, 1557-1567.
20. Kaminsky, L.S. and Zhang, Z. Y. (1997): Human P450 metabolism of warfarin. Pharmacol. Ther, 73, 67-74.
21. Kirchheiner, J. and Brockmöller, J. (2005): Clinical consequences of cytochrome P450 2C9 polymorphisms. Clin. Pharmacol. Ther., 77, 1-16.
22. Kohn, M.H., Pelz, H.J. and Wayne, R.K. (2000): Natural selection mapping of the warfarin-resistance gene. Proc. Natl. Acad. Sci. USA, 97, 7911-7915.
23. Kohn, M.H., Pelz, H.J. and Wayne, R.K. (2003): Locus-specific genetic differentiation at Rw among warfarin-resistant rat (Rattus norvegicus) populations. Genetics, 164, 1055-1070.
24. Kotsaftis, P., Girtovitis, F., Boutou, A., Ntaios, G. and Makris, P.E. (2007): Haemarthrosis after superwarfarin poisoning. Eur. J. Haematol., 79, 255-257.
25. Lasseur, R., Grandemange, A., Longin-Sauvageon, C., Berny, P. and Benoit, E. (2006): Heterogeneity of the coumarin anticoagulant targeted vitamin K epoxide reduction system. Study of kinetic parameters in susceptible and resistant mice (Mus musculus domesticus). J. Biochem. Mol. Toxicol., 20, 221-229.
26. Lasseur, R., Longin-Sauvageon, C., Videmann, B., Billeret, M., Berny, P. and Benoit, E. (2006): Warfarin resistance in a French strain of rats. J. Biochem. Mol. Toxicol., 19, 379-385.
27. Li, T., Chang, C.Y., Jin, D.Y., Lin, P.J., Khvorova, A. and Stafford, D.W. (2004): Identification of the gene for vitamin K epoxide reductase. Nature. 427, 541-544.
28. Lund, M. (1967): The resistance to anticoagulants. Dan. Pest. Infest. Lab., 47, 611-618.
29. Lund, M. (1984): Resistance to the second-generation anticoagulant rodenticides. Proc. Vertebrate Pest. Conf., 11, 89-94.
30. Markussen, M.D., Heiberg, A.C., Nielsen, R. and Leirs, H. (2003): Vitamin K requirement in Danish anticoagulant-resistant Norway rats (Rattus norvegicus). Pest. Manag. Sci., 59, 913-920.
31. Myllymäki, A. (1995): Anticoagulant resistance in Europe: appraisal of the data from the 1992 EPPO questionnaire. Pesticide Sci., 43, 69-72.
32. Naganuma, K., Fujita, A., Taniguchi, N. and Takada, S. (1981): Warfarin susceptibility in the roof rat, Rattus rattus, in some locations of Tokyo. Jap. J. Sanit. Zool., 32, 243-245.
33. Nebert, D. and Russell, D. (2002): Clinical importance of the cytochromes P450. Lancet, 360, 1155-1162.
34. Nelson, D.R., Zeldin, D.C., Hoffman, S.M., Maltais, L.J., Wain, H.M. and Nebert, D.W. (2004): Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics, 14, 1-18.
35. Pelz, H.J., Rost, S., Hunerberg, M., Fregin, A., Heiburg, A.C., Baert, K., MacNicoll, A.D., Prescott, C.V., Walker, A.S., Oldenburg, J. and Müller, C.R. (2005): The genetic basis of resistance to anticoagulants in rodents. Genetics, 170, 1839-1847.
36. Petterino, C. and Paolo, B. (2001): Toxicology of various anticoagulant rodenticides in animals. Vet. Hum. Toxicol., 43, 353-360.
37. Rost, S., Fregin, A., Ivaskevicius, V., Conzelmann, E., Hörtnagel, K., Pelz, H.J., Lappegard, K., Seifried, E., Scharrer, I., Tuddenham, E.G.D., Müller, C.R., Strom, T.M. and Oldenburg, J. (2004): Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature, 427, 537-541.
38. Rost, S., Fregin, A., Hünerberg, M., Bevans, C.G., Müller, C.R. and Oldenburg, J. (2005): Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements of enzymatic activity and inhibition by warfarin. Thromb. Haemost., 94, 780-786.
39. Saunders, G.R. (1978): Resistance to warfarin in the roof rat in Sydney. NSW Search, 9, 39-40.
40. Scott, J.G. (1999): Cytochromes P450 and insecticide resistance. Insect. Biochem. Molec. Biol., 29, 757-777.
41. Siddiqi, Z. and Blaine, W.D. (1982): Anticoagulant resistance in house mice in Toronto, Canada Environ. Health Rev., 32, 49-51.
42. Spahr, J.E., Maul, J.S. and Rodgers, G.M. (2007): Superwarfarin poisoning: a report of two cases and review of the literature. Am. J. Hematol., 82, 656-660.
43. Stafford, D.W. (2005): The vitamin K cycle. J. Thromb. Haemost., 3, 1873-1878.
44. Stone, W.B., Okoniewski, J.C. and Stedelin, J.R. (1999): Poisoning of wildlife with anticoagulant rodenticides in New York. J. Wildl. Dis., 35, 187-193.
45. Sugano, S., Kobayashi, T., Tanikawa, T., Kawakami, Y., Kojima, H., Nakamura, K., Uchida, A., Morishima, N. and Tamai, Y. (2001): Suppression of CYP3A2 mRNA expression in the warfarin-resistant roof rat, Rattus rattus: Possible involvement of cytochrome P450 in the warfarin-resistance mechanism. Xenobiotica, 31, 399-407.
46. Suttie, J.W. (1985): Vitamin K-dependent carboxylase. Annu. Rev. Biochem., 54, 459-477.
47. Telle, H. (1971): Resistance to warfarin of the brown rat Rattus norvregicus in Germany. WHO Bull., 45, 331-334.
48. Thyssen, H.H., Janssen, C.A. and Mosterd, J.J. (1989): Warfarin resistance: biochemical evaluation of a warfarin-resistant wild brown rat. Biochem. Pharmacol., 38, 3129-32.
49. Thijssen, H.H., Soute, B.A., Vervoort, L.M. and Ciaessens, J.G. (2004): Paracetamol (acetaminophen)-warfarin interaction: NAPQ1, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle. Thromb. Haemost., 92, 797-802.
50. Uno, T., Sugimoto, K., Sugawara, K. and Tateishi, T. (2008): The effect of CYP2C19 genotypes on the pharmacokinetics of warfarin enantiomers. J. Clin. Pharm. Ther., 33, 67-73.
51. Wajih, N., Hutson, S.M. and Wallin, R. (2007): Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKO-RC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction. J. Biol. Chem., 282, 2626-2635.
52. Wajih, N., Sane, D.C., Hutson, S.M. and Wallin, R. (2005): Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity: evidence for a functional CXXC redox center in the system. J. Biol. Chem., 280, 10540-10547.
53. Wallin, R., Hutson, S.M., Cain, D., Sweatt, A. and Sane, D.C. (2001): A molecular mechanism for genetic warfarin resistance in the rat. FASEB J., 15, 2542-2544.
54. Wallin, R. and Hutson, S.M. (2004): Warfarin and the vitamin K-dependent gamma-carboxylation system. Trends Mol. Med., 10, 299-302.
55. Werck-Reichhart, D. and Feyereisen, R. (2000): Cytochromes P450: a success story. Genome Biol., 1, REVIEWS3003.
56. World Health Organization. (1995): Anticoagulant rodenticides. Environmental Health Criteria, 175.